Objectives
After participating in this educational activity, attendees should be able to:
1. Describe the investigator’s responsibilities when conducting a trial
2. Identify and analyze the IRB assessment of ethical and regulatory responsibilities
3. Analyze the ethical and practical issues surrounding the risk to subjects when designing and implementing protocols
4. Analyze how lessons learned from previous cases of abuse can help inform protections for future research subjects
5. List the four levels of scale of measurement of variables
6. Explain the difference between a dependent variable and independent variable
7. Discuss the distinction between “statistical significance” and “clinical significance”
8. List three reasons for conducting pilot studies
Faculty
Jennifer Pacheco MPH
Chief Research Compliance Officer
Director, Healthcare Research Compliance
UMMS-Baystate
Paul Visintainer, PhD
Professor of Medicine, UMMS-Baystate
Director, Scientific Integrity & Analytics
Director of Epidemiology & Biostatistics
Baystate Health
Faculty Disclosure
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 2.00 AMA PRA Category 1 Credit™